鼻后神经切除术联合经鼻激素雾化治疗难治性鼻炎的疗效:回顾性分析

IF 1.7 4区 医学 Q2 OTORHINOLARYNGOLOGY Brazilian Journal of Otorhinolaryngology Pub Date : 2024-03-01 DOI:10.1016/j.bjorl.2024.101413
Xin-ke Wang , Qi-ling Zheng , Jia-ning Sun
{"title":"鼻后神经切除术联合经鼻激素雾化治疗难治性鼻炎的疗效:回顾性分析","authors":"Xin-ke Wang ,&nbsp;Qi-ling Zheng ,&nbsp;Jia-ning Sun","doi":"10.1016/j.bjorl.2024.101413","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>A retrospective analysis was performed to explore the clinical effect of the Posterior Nasal Nerve (PNN) resection combined with hormone transnasal nebulization on Difficult-to-Treat Rhinosinusitis (DTRS).</p></div><div><h3>Methods</h3><p>A total of 120 DTRS patients were selected and divided into a control group (<em>n</em> = 60) and a study group (<em>n</em> = 60) according to different treatments. The control group patients were treated via PNN resection, followed by normal saline transnasal nebulization; the study group patients were given PNN resection and then treated with budesonide suspension transnasal nebulization. Subsequently, the comparison was performed between the two groups in terms of (1) Clinical baseline characteristics; (2) Sino-nasal Outcome Test (SNOT)-22 scores before treatment and after 3-months, 6-months and 12-months of treatment; (3) Lund-MacKay scores before treatment and after 10, 30, 90, and 180 days of treatment; (4) Incidence of adverse reactions during treatment.</p></div><div><h3>Results</h3><p>There was no significant difference in SNOT-22 or Lund-Kennedy scores between the two groups before treatment (<em>p</em> &gt; 0.05). After treatment, the SNOT-22 and Lund-Kennedy scores of the control and the study groups were decreased, and compared with the control group, the SNOT-22 and Lund-Kennedy scores in the study group improved more significantly (<em>p</em> &lt; 0.05). In addition, the study group and the control group presented with 1 and 4 cases of nasal adhesion, 2 and 3 cases of epistaxis, 1 and 4 cases of sinus orifice obstruction, 1 and 3 cases of lacrimal duct injuries, respectively. The incidence of adverse reactions in the study group was significantly lower than that in the control group (8.3% vs. 23.3%) (<em>p</em> &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>PNN resection combined with hormone transnasal nebulization treatment can improve the symptoms and quality of life of DTRS patients, with good clinical efficacy but few adverse reactions. Therefore, such combination treatment deserves a promotion and application clinically.</p></div><div><h3>Level of Evidence</h3><p>Level 3.</p></div>","PeriodicalId":49099,"journal":{"name":"Brazilian Journal of Otorhinolaryngology","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1808869424000284/pdfft?md5=dd0d56463d474c5c472f5e5fe87c2b58&pid=1-s2.0-S1808869424000284-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Efficacy of the posterior nasal nerve resection combined with hormone transnasal nebulization on difficult-to-treat rhinosinusitis: a retrospective analysis\",\"authors\":\"Xin-ke Wang ,&nbsp;Qi-ling Zheng ,&nbsp;Jia-ning Sun\",\"doi\":\"10.1016/j.bjorl.2024.101413\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>A retrospective analysis was performed to explore the clinical effect of the Posterior Nasal Nerve (PNN) resection combined with hormone transnasal nebulization on Difficult-to-Treat Rhinosinusitis (DTRS).</p></div><div><h3>Methods</h3><p>A total of 120 DTRS patients were selected and divided into a control group (<em>n</em> = 60) and a study group (<em>n</em> = 60) according to different treatments. The control group patients were treated via PNN resection, followed by normal saline transnasal nebulization; the study group patients were given PNN resection and then treated with budesonide suspension transnasal nebulization. Subsequently, the comparison was performed between the two groups in terms of (1) Clinical baseline characteristics; (2) Sino-nasal Outcome Test (SNOT)-22 scores before treatment and after 3-months, 6-months and 12-months of treatment; (3) Lund-MacKay scores before treatment and after 10, 30, 90, and 180 days of treatment; (4) Incidence of adverse reactions during treatment.</p></div><div><h3>Results</h3><p>There was no significant difference in SNOT-22 or Lund-Kennedy scores between the two groups before treatment (<em>p</em> &gt; 0.05). After treatment, the SNOT-22 and Lund-Kennedy scores of the control and the study groups were decreased, and compared with the control group, the SNOT-22 and Lund-Kennedy scores in the study group improved more significantly (<em>p</em> &lt; 0.05). In addition, the study group and the control group presented with 1 and 4 cases of nasal adhesion, 2 and 3 cases of epistaxis, 1 and 4 cases of sinus orifice obstruction, 1 and 3 cases of lacrimal duct injuries, respectively. The incidence of adverse reactions in the study group was significantly lower than that in the control group (8.3% vs. 23.3%) (<em>p</em> &lt; 0.05).</p></div><div><h3>Conclusion</h3><p>PNN resection combined with hormone transnasal nebulization treatment can improve the symptoms and quality of life of DTRS patients, with good clinical efficacy but few adverse reactions. Therefore, such combination treatment deserves a promotion and application clinically.</p></div><div><h3>Level of Evidence</h3><p>Level 3.</p></div>\",\"PeriodicalId\":49099,\"journal\":{\"name\":\"Brazilian Journal of Otorhinolaryngology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1808869424000284/pdfft?md5=dd0d56463d474c5c472f5e5fe87c2b58&pid=1-s2.0-S1808869424000284-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brazilian Journal of Otorhinolaryngology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1808869424000284\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"OTORHINOLARYNGOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brazilian Journal of Otorhinolaryngology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1808869424000284","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

一项回顾性分析旨在探讨鼻后神经(PNN)切除术联合激素经鼻雾化吸入对难治性鼻炎(DTRS)的临床效果。研究人员共选取了 120 例鼻窦炎患者,按照不同的治疗方法将其分为对照组(60 例)和研究组(60 例)。对照组患者接受 PNN 切除术,然后用生理盐水经鼻雾化吸入治疗;研究组患者接受 PNN 切除术,然后用布地奈德混悬液经鼻雾化吸入治疗。随后,两组患者在以下方面进行了比较:(1) 临床基线特征;(2) 治疗前及治疗 3 个月、6 个月和 12 个月后的中鼻结果测试(SNOT)-22 评分;(3) 治疗前及治疗 10 天、30 天、90 天和 180 天后的 Lund-MacKay 评分;(4) 治疗期间的不良反应发生率。治疗前,两组的 SNOT-22 和 Lund-Kennedy 评分无明显差异(> 0.05)。治疗后,对照组和研究组的 SNOT-22 和 Lund-Kennedy 评分均有所下降,与对照组相比,研究组的 SNOT-22 和 Lund-Kennedy 评分改善更为明显(< 0.05)。此外,研究组和对照组分别出现鼻腔粘连 1 例和 4 例、鼻衄 2 例和 3 例、鼻窦口阻塞 1 例和 4 例、泪管损伤 1 例和 3 例。研究组的不良反应发生率(8.3% 对 23.3%)明显低于对照组(< 0.05)。PNN 切除术联合激素经鼻雾化治疗可改善 DTRS 患者的症状和生活质量,临床疗效好,不良反应少。因此,这种联合治疗值得在临床上推广应用。三级。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Efficacy of the posterior nasal nerve resection combined with hormone transnasal nebulization on difficult-to-treat rhinosinusitis: a retrospective analysis

Objective

A retrospective analysis was performed to explore the clinical effect of the Posterior Nasal Nerve (PNN) resection combined with hormone transnasal nebulization on Difficult-to-Treat Rhinosinusitis (DTRS).

Methods

A total of 120 DTRS patients were selected and divided into a control group (n = 60) and a study group (n = 60) according to different treatments. The control group patients were treated via PNN resection, followed by normal saline transnasal nebulization; the study group patients were given PNN resection and then treated with budesonide suspension transnasal nebulization. Subsequently, the comparison was performed between the two groups in terms of (1) Clinical baseline characteristics; (2) Sino-nasal Outcome Test (SNOT)-22 scores before treatment and after 3-months, 6-months and 12-months of treatment; (3) Lund-MacKay scores before treatment and after 10, 30, 90, and 180 days of treatment; (4) Incidence of adverse reactions during treatment.

Results

There was no significant difference in SNOT-22 or Lund-Kennedy scores between the two groups before treatment (p > 0.05). After treatment, the SNOT-22 and Lund-Kennedy scores of the control and the study groups were decreased, and compared with the control group, the SNOT-22 and Lund-Kennedy scores in the study group improved more significantly (p < 0.05). In addition, the study group and the control group presented with 1 and 4 cases of nasal adhesion, 2 and 3 cases of epistaxis, 1 and 4 cases of sinus orifice obstruction, 1 and 3 cases of lacrimal duct injuries, respectively. The incidence of adverse reactions in the study group was significantly lower than that in the control group (8.3% vs. 23.3%) (p < 0.05).

Conclusion

PNN resection combined with hormone transnasal nebulization treatment can improve the symptoms and quality of life of DTRS patients, with good clinical efficacy but few adverse reactions. Therefore, such combination treatment deserves a promotion and application clinically.

Level of Evidence

Level 3.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.00
自引率
0.00%
发文量
205
审稿时长
4-8 weeks
期刊介绍: Brazilian Journal of Otorhinolaryngology publishes original contributions in otolaryngology and the associated areas (cranio-maxillo-facial surgery and phoniatrics). The aim of this journal is the national and international divulgation of the scientific production interesting to the otolaryngology, as well as the discussion, in editorials, of subjects of scientific, academic and professional relevance. The Brazilian Journal of Otorhinolaryngology is born from the Revista Brasileira de Otorrinolaringologia, of which it is the English version, created and indexed by MEDLINE in 2005. It is the official scientific publication of the Brazilian Association of Otolaryngology and Cervicofacial Surgery. Its abbreviated title is Braz J Otorhinolaryngol., which should be used in bibliographies, footnotes and bibliographical references and strips.
期刊最新文献
Brazilian Society of Otology task force – single sided deafness – recommendations based on strength of evidence Correlation between vestibular response to caloric stimulation and cochlear function in Ménière's disease Translation, adaptation, and validation of ASK nasal-12 into Brazilian Portuguese A case of extranasopharyngeal angiofibroma arising from nasal dorsum Evaluation of epithelial-to-mesenchymal transition and Ki-67 index in aggressive papillary thyroid cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1